Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedVersion 71 (2026-02-06) added Contacts/Locations and updated Study Status, with Revision: v3.4.2. The funding-notice banner from 2026-01-20 was removed.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the record history now lists revision v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle, color-coded additions and deletions, and updated revision notes to v3.4.0, replacing the previous 'No FEAR Act data' entry and v3.3.4.SummaryDifference0.5%

- Check35 days agoChange DetectedVersion 70 adds Study Status and Contacts/Locations around 2026-01-16, with a follow-up update on 2026-01-20, and the 2026-01-09 entry was removed.SummaryDifference0.2%

- Check42 days agoChange DetectedVersion 69 adds Contacts/Locations and Study Status to the record history (Revision: v3.3.4), replacing the previous v3.3.3 entry.SummaryDifference0.3%

- Check49 days agoChange DetectedOn 2026-01-05, Contacts/Locations and Study Status were added. On 2025-12-23, a deletion was made.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.